Skip to main content
. 2018 Jan 17;92(3):e01688-17. doi: 10.1128/JVI.01688-17

TABLE 3.

Neutralizing antibody IC50 titers against the wild-type and mutant clones with monoclonal antibodies targeting the V2, V3, and CD4bs regions

Tier Clone IC50 (μg/ml)
V2 V3 CD4bs
1 wt 0.045 0.016 0.028
ΔCT >50 >50 >50
2 wt 5.260 0.065 0.160
ΔCT >50 >50 >50
3 wt >50 >50 >50
ΔCT >50 >50 >50